Andreas Spannbauer
Impact in
-
- Cardiovascular Function and Risk Factors
- Cardiac Fibrosis and Remodeling
- Chemotherapy-induced cardiotoxicity and mitigation
- Heart Failure Treatment and Management
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
-
- Cardiac Fibrosis and Remodeling 7
- Atrial Fibrillation Management and Outcomes 4
- Cardiac Valve Diseases and Treatments 4
-
- Circular RNAs in diseases 8
- Co-authors
- Mariann Gyöngyösi (40 shared papers)Denise Traxler (29 shared papers)Katrin Zlabinger (30 shared papers)Dominika Lukovic (26 shared papers)Johannes Winkler (18 shared papers)Ena Hašimbegović (18 shared papers)Martin Riesenhuber (15 shared papers)Alfred Gugerell (13 shared papers)
In The Last Decade
Andreas Spannbauer
38 papers receiving 606 citations
Peers
Comparison fields: 5 of 81
- Cardiology and Cardiovascular Medicine 252
- Cancer Research 141
- Molecular Biology 297
- Biomaterials 37
- Neurology 41
Countries citing papers authored by Andreas Spannbauer
This map shows the geographic impact of Andreas Spannbauer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Spannbauer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Spannbauer more than expected).
Fields of papers citing papers by Andreas Spannbauer
This network shows the impact of papers produced by Andreas Spannbauer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Spannbauer. The network helps show where Andreas Spannbauer may publish in the future.
Co-authors
The 25 scholars most cited alongside Andreas Spannbauer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 108 | |
| 2 | 2019 | 68 | |
| 3 | 2022 | 55 | |
| 4 | 2019 | 40 | |
| 5 | 2021 | 33 | |
| 6 | 2017 | 32 | |
| 7 | 2019 | 29 | |
| 8 | 2021 | 27 | |
| 9 | 2020 | 27 | |
| 10 | 2021 | 26 | |
| 11 | 2016 | 18 | |
| 12 | 2020 | 15 | |
| 13 | 2020 | 13 | |
| 14 | 2019 | 13 | |
| 15 | 2019 | 12 | |
| 16 | 2020 | 10 | |
| 17 | 2020 | 10 | |
| 18 | 2020 | 8 | |
| 19 | 2020 | 8 | |
| 20 | 2020 | 8 |
About Andreas Spannbauer
Andreas Spannbauer is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology, Surgery, Cancer Research and Neurology, having authored 42 papers that have together received 606 indexed citations. Recurring topics across this work include Circular RNAs in diseases (8 papers), Cardiac Fibrosis and Remodeling (7 papers), MicroRNA in disease regulation (7 papers), Long-Term Effects of COVID-19 (5 papers), Tissue Engineering and Regenerative Medicine (5 papers), Coronary Interventions and Diagnostics (5 papers), Atrial Fibrillation Management and Outcomes (4 papers) and Cardiac Valve Diseases and Treatments (4 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (252 citations), Cancer Research (141 citations), Molecular Biology (297 citations), Biomaterials (37 citations) and Neurology (41 citations). Andreas Spannbauer has collaborated with scholars based in Austria, Germany and Hungary. Frequent co-authors include Mariann Gyöngyösi, Denise Traxler, Katrin Zlabinger, Dominika Lukovic, Johannes Winkler, Ena Hašimbegović, Martin Riesenhuber, Alfred Gugerell, Noémi Pávó and Georg Goliasch. Their work appears in journals such as International Journal of Molecular Sciences, Biomolecules, Cardiovascular Research, European Heart Journal and Frontiers in Cardiovascular Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.